I don't doubt that's true, while they can maintain control. Right now, they can. I would suggest that they're helping the shorts, who they've been supporting for years, to unwind their positions. The naked short position is huge, the volume isn't that great, but with each day at these prices smart shorts are reducing their positions without putting upward pressure on the stock.
Today our volume was under 3 million shares. I certainly don't know, but with computerized trading buying and selling at fractions of a cent in share price I'd not be surprised if a billion shares traded on the day UK approval is announced. Certainly I may be wrong, perhaps it won't get that much attention, 100 million would be a huge day, but regardless of the numbers, shorts who've failed to eliminate their positions will be hard pressed to do so without taking huge losses unless they established their positions when the stock was selling for many dollars. The shorts may be hoping some retrenchment occurs before brokers demands have to be met, but if media attention is strong, if the general public learns of a new paradigm in the treatment of cancer, it will be some time before the stock retrenches from new 52 week highs. The short squeeze should be something beautiful for us longs.
Gary
AI
Market Data 
Markets 
